FindTrial
Sign In

To compare and analyse the effect of Nigella sativa oil as an add-on therapy in addition to alpha Keto analogue of essential amino acids, in the conservative management of Chronic Kidney Disease

To study the effect of Nigella sativa oil as an add-on therapy in addition to alpha Keto analogue of essential amino acids, in the conservative management of Chronic Kidney Disease

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011429
Enrollment
160
Registered
2018-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Kidney Disease

Interventions

Intervention1: conservative management plus alpha keto analogue of essential amino acid and Nigella sativa oil.: conservative management of CKD as per standard protocols of KDIGO and KAA 600 mg 3 time

Sponsors

JN medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Chronic kidney disease of different etiology, before ESRD. 2.Patient not on any renal replacement therapy. 3.Age Ë? 18 years.

Exclusion criteria

Exclusion criteria: 1.Acute on Chronic Kidney Disease. 2.Pregnancy. 3.Psychotic patients. 4.Critically ill patients. 5.HIV/HBsAg /Anti-HCV and immune-compromised patients. Patient on any form of Renal Replacement Therapy.

Design outcomes

Primary

MeasureTime frame
1.Haemogram 2.Blood Glucose- Fasting & Post Prandial 3.Total Urine Protein (TUP) in 24 hour sample. 4.Blood Urea 5.Serum Creatinine 6.Estimated GFR(ml/min per 1.73 m2) 7.Serum Ca++ 8.Serum Electrolytes ( Na+ , K+ )Timepoint: 0,4,8 and 12 weeks—

Secondary

MeasureTime frame
1.LFT 2.LIPID PROFILE 3.USG ABDOMENTimepoint: 0 and 12 weeks—

Countries

India

Contacts

Public ContactMOHD ASHRAF ALAM

JN Medical College, AMU. Aligarh

drrakhan@yahoo.co.in8755547593

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026